menu
    • menu

    Company profile for Pharmacyclics

    Abbvie Contract Manufacturing-PSE
    News
    IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib

    23 Jun 2020

    // PHARMABIZ

    Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs

    23 Mar 2020

    // Gireesh Babu BUSINESS-STANDARD

    Swiss biotech ADC Therapeutics guns for $150M IPO

    09 Sep 2019

    // Ben Adams FIERCEBIOTECH

    DATA COMPILATION
    #PharmaFlow

    Pharmacyclics VB RM

    Contact Supplier

    Website

    Antibody Engineering

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    Pharmacyclics is an AbbVie company based in the Bay Area, California. Our charge is to help people impacted by cancer and immune-mediated diseases by focusing on the development of safe and effective treatment options. We will know that our mission has been achieved when patients and their families have rediscovered the Magic of Normal – where disease no longer defines the every day.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmacyclicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    999 East Arques AvenueSunnyvale, California 94085
    Telephone
    Telephone
    +1 408-774-0330
    Client Email
    Email
    abbviecontractmfg@abbvie.com
    Client Website
    Website
    https://www.pharmacyclics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pharmacyclics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Pharmacyclics
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib
    IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib

    23 Jun 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=129058&sid=1

    PHARMABIZ
    23 Jun 2020
    Share Share
    Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs
    Patent for Pharmacyclic's cancer drug revoked on challenge by Laurus Labs

    23 Mar 2020

    // Gireesh Babu BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/patent-for-pharmacyclic-s-cancer-drug-revoked-on-challenge-by-laurus-labs-120032100944_1.html

    Gireesh Babu BUSINESS-STANDARD
    23 Mar 2020
    Share Share
    Swiss biotech ADC Therapeutics guns for $150M IPO
    Swiss biotech ADC Therapeutics guns for $150M IPO

    09 Sep 2019

    // Ben Adams FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/swiss-biotech-adc-therapeutics-guns-for-150m-ipo

    Ben Adams FIERCEBIOTECH
    09 Sep 2019
    Share Share
    Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS
    Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS

    02 Jul 2019

    // Kyle Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/big-pharma-hits-3b-payments-to-doctors-and-teaching-hospitals-cms

    Kyle Blankenship FIERCE PHARMA
    02 Jul 2019
    Share Share
    AstraZeneca's Calquence treads on Imbruvica's turf with second phase 3 CLL win
    AstraZeneca's Calquence treads on Imbruvica's turf with second phase 3 CLL win

    07 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astrazeneca-s-calquence-treads-imbruvica-s-turf-second-ph3-cll-win

    Carly Helfand FIERCE PHARMA
    07 Jun 2019
    Share Share
    AbbVie unveils Venclexta data
    AbbVie unveils Venclexta data

    04 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/abbvie-unveils-venclexta-data-scored-lightning-fast-cll-combo-nod

    Carly Helfand FIERCE PHARMA
    04 Jun 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search